Medical progress: Multiple sclerosis - The plaque and its pathogenesis

被引:1284
作者
Frohman, EM
Racke, MK
Raine, CS
机构
[1] Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA
[3] Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA
[4] Albert Einstein Coll Med, Div Neuropathol, Dept Pathol & Neurol, Bronx, NY 10467 USA
关键词
D O I
10.1056/NEJMra052130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:942 / 955
页数:14
相关论文
共 80 条
[1]   ENCEPHALITOGENIC T-CELLS IN THE B10.PL MODEL OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE) ARE OF THE TH-1 LYMPHOKINE SUBTYPE [J].
ANDO, DG ;
CLAYTON, J ;
KONO, D ;
URBAN, JL ;
SERCARZ, EE .
CELLULAR IMMUNOLOGY, 1989, 124 (01) :132-143
[2]   bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS [J].
Arnett, HA ;
Fancy, SPJ ;
Alberta, JA ;
Zhao, C ;
Plant, SR ;
Kaing, S ;
Raine, CS ;
Rowitch, DH ;
Franklin, RJM ;
Stiles, CD .
SCIENCE, 2004, 306 (5704) :2111-2115
[3]   INHIBITION OF T-CELL RESPONSES BY ACTIVATED HUMAN CD8+ T-CELLS IS MEDIATED BY INTERFERON-GAMMA AND IS DEFECTIVE IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS [J].
BALASHOV, KE ;
KHOURY, SJ ;
HAFLER, DA ;
WEINER, HL .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2711-2719
[4]   Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion [J].
Barnett, MH ;
Prineas, JW .
ANNALS OF NEUROLOGY, 2004, 55 (04) :458-468
[5]   Axonal protection using flecainide in experimental autoimmune encephalomyelitis [J].
Bechtold, DA ;
Kapoor, R ;
Smith, KJ .
ANNALS OF NEUROLOGY, 2004, 55 (05) :607-616
[6]   Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis [J].
Bettelli, E ;
Sullivan, B ;
Szabo, SJ ;
Sobel, RA ;
Glimcher, H ;
Kuchroo, VK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (01) :79-87
[7]  
Bielekova B, 2000, NAT MED, V6, P1412
[8]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[9]   Acute axonal injury in multiple sclerosis -: Correlation with demyelination and inflammation [J].
Bitsch, A ;
Schuchardt, J ;
Bunkowski, S ;
Kuhlmann, T ;
Brück, W .
BRAIN, 2000, 123 :1174-1183
[10]  
Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO